COSCIA, MARTA
COSCIA, MARTA
DIPARTIMENTO DI MEDICINA E CHIRURGIA
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS
2014-01-01 Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, Marta; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, Massimo; Tedeschi, A.
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients
2015-01-01 Tedeschi, Alessandra; Rossi, Davide; Motta, Marina; Quaresmini, Giulia; Rossi, Marianna; Coscia, Marta; Anastasia, Antonella; Rossini, Fausto; Cortelezzi, Agostino; Nador, Guido; Scarfo, Lydia; Cairoli, Roberto; Frustaci, Anna Maria; Dalceggio, Daniela; Picardi, Paola; de Paoli, Lorenzo; Orlandi, Ester; Rambaldi, Alessandro; Massaia, Massimo; Gaidano, Gianluca; Montillo, Marco
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia
2019-01-01 Visentin, A.; Deodato, M.; Mauro, F. R.; Autore, F.; Reda, G.; Vitale, C.; Molica, S.; Rigolin, G. M.; Piazza, F.; Cesini, L.; Tedeschi, A.; Laurenti, L.; Cassin, R.; Coscia, M.; Cuneo, A.; Foa, R.; Semenzato, G.; Trentin, L.
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells
2019-01-01 Todaro, Maria; Griggio, Valentina; Salvetti, Chiara; Riganti, Chiara; Landesman, Yosef; Boccadoro, Mario; Vitale, Candida; Coscia, Marta
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 Coscia, Marta; Rigoni, MICOL MARIA; Riganti, Chiara; Campia, Ivana; Vitale, Candida; Griggio, Valentina; S., Peola; Castella, Barbara; Pantaleoni, Francesca; Sciancalepore, Patrizia; Drandi, Daniela; P., Omedè; Ladetto, Marco; Bosia, Amalia; Boccadoro, Mario; Massaia, Massimo
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment
2015-01-01 Serra, Sara; Brusa, Davide; Vaisitti, Tiziana; Buonincontri, Roberta; Audrito, Valentina; Coscia, Marta; Rossi, D; Bhavsar, Eb; Furman, Rr; Gaidano, G; Deaglio, Silvia
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment
2016-01-01 Serra, Sara; Vaisitti, Tiziana; Audrito, Valentina; Bologna, Cinzia; Buonincontri, Roberta; Chen, Shih Shih; Arruga, Francesca; Brusa, Davide; Coscia, Marta; Jaksic, Ozren; Inghirami, Giorgio; Rossi, Davide; Furman, Richard R.; Robson, Simon C.; Gaidano, Gianluca; Chiorazzi, Nicholas; Deaglio, Silvia
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives
2019-01-01 Coscia, Marta; Vitale, Candida; Cerrano, Marco; Maffini, Enrico; Giaccone, Luisa; Boccadoro, Mario; Bruno, Benedetto
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
2015-01-01 Castella, Barbara; Foglietta, Myriam; Sciancalepore, Patrizia; Rigoni, MICOL MARIA; Coscia, Marta; Griggio, Valentina; Vitale, Candida; Ferracini, R; Saraci, E; Omedé, P; Riganti, Chiara; Palumbo, Antonio; Boccadoro, Mario; Massaia, Massimo
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS
2015-01-01 Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, Marta; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS
2015-01-01 Autore, F; Innocenti, I; D'Arena, G; Coscia, Marta; Mondello, P; Pasquale, R; Sica, S; Laurenti, L.
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience
2016-01-01 Laurenti, Luca; Autore, Francesco; Innocenti, Idanna; D’Arena, Giovanni; Coscia, Marta; Mondello, Patrizia; Chiusolo, Patrizia; Bellesi, Silvia; Efremov, Dimitar G.; Sica, Simona; Mauro, Francesca Romana
B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide
2018-01-01 Fuerstenau, Moritz; Fink, Anna-Maria; Herling, Carmen; Maurer, Christian; Kutsch, Nadine; De La Serna, Javier; Coscia, Marta; Crespo, Marta; Bosch, Francesc; Noesslinger, Thomas; Ghia, Paolo; Kater, Arnon P.; Ritgen, Matthias; Schilhabel, Anke; Stilgenbauer, Stephan; Tausch, Eugen; Fischer, Kirsten; Hallek, Michael J.; Eichhorst, Barbara
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial
2011-01-01 A., Tedeschi; Coscia, Marta; D., Rossi; F., Ricci; G., D'Arena; E., Orlandi; V., Belsito Petrizzi; L., Scarfò; Vitale, Candida; E., Vismara; G., Gaidano; E., Morra; Massaia, Massimo; M., Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
2010-01-01 A., Tedeschi; Coscia, Marta; D., Rossi; E., Vismara; F., Ricci; Vitale, Candida; E., Morra; G., Gaidano; Massaia, Massimo; M., Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL
2011-01-01 Tedeschi, A; Coscia, Marta; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, Candida; Vismara, E; Gaidano, G; Morra, E; Massaia, Massimo; Montillo, M.
Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial
2011-01-01 A., Tedeschi; Coscia, Marta; D., Rossi; F., Ricci; G., D'Arena; E., Orlandi; V., Belsito Petrizzi; L., Scarfò; Vitale, Candida; E., Vismara; G., Gaidano; E., Morra; Massaia, Massimo; M., Montillo
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients
2014-01-01 M., Montillo; A., Tedeschi; G., Gaidano; Coscia, Marta; V., Belsito Petrizzi; E., Orlandi; N., Cascavilla; P., Ghia; M., Motta; A., Gallamini; A. M., Frustaci; D., Rossi; L., De Paoli; M., Nichelatti; E., Morra; Massaia, Massimo
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications
2019-01-01 Arruga, F; Bracciamà, V; Vitale, N; Vaisitti, T; Gizzi, K; Yeomans, A; Coscia, M; D'Arena, G; Gaidano, G; Allan, Jn; Furman, Rr; Packham, G; Forconi, F; Deaglio, S
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
2019-01-01 Diop, Fary; Moia, Riccardo; Favini, Chiara; Spaccarotella, Elisa; De Paoli, Lorenzo; Bruscaggin, Alessio; Spina, Valeria; Terzi-di-Bergamo, Lodovico; Arruga, Francesca; Tarantelli, Chiara; Deambrogi, Clara; Rasi, Silvia; Adhinaveni, Ramesh; Patriarca, Andrea; Favini, Simone; Sagiraju, Sruthi; Jabangwe, Clive; Kodipad, Ahad A; Peroni, Denise; Mauro, Francesca R; Del Giudice, Ilaria; Forconi, Francesco; Cortelezzi, Agostino; Zaja, Francesco; Bomben, Riccardo; Rossi, Francesca Maria; Visco, Carlo; Chiarenza, Annalisa; Rigolin, Gian Matteo; Marasca, Roberto; Coscia, Marta; Perbellini, Omar; Tedeschi, Alessandra; Laurenti, Luca; Motta, Marina; Donaldson, David; Weir, Phil; Mills, Ken; Thornton, Patrick; Lawless, Sarah; Bertoni, Francesco; Del Poeta, Giovanni; Cuneo, Antonio; Follenzi, Antonia; Gattei, Valter; Boldorini, Renzo Luciano; Catherwood, Mark; Deaglio, Silvia; Foá, Robin; Gaidano, Gianluca; Rossi, Davide
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS | 1-gen-2014 | Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, Marta; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, Massimo; Tedeschi, A. | |
| A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients | 1-gen-2015 | Tedeschi, Alessandra; Rossi, Davide; Motta, Marina; Quaresmini, Giulia; Rossi, Marianna; Coscia, Marta; Anastasia, Antonella; Rossini, Fausto; Cortelezzi, Agostino; Nador, Guido; Scarfo, Lydia; Cairoli, Roberto; Frustaci, Anna Maria; Dalceggio, Daniela; Picardi, Paola; de Paoli, Lorenzo; Orlandi, Ester; Rambaldi, Alessandro; Massaia, Massimo; Gaidano, Gianluca; Montillo, Marco | |
| A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia | 1-gen-2019 | Visentin, A.; Deodato, M.; Mauro, F. R.; Autore, F.; Reda, G.; Vitale, C.; Molica, S.; Rigolin, G. M.; Piazza, F.; Cesini, L.; Tedeschi, A.; Laurenti, L.; Cassin, R.; Coscia, M.; Cuneo, A.; Foa, R.; Semenzato, G.; Trentin, L. | |
| Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 1-gen-2019 | Todaro, Maria; Griggio, Valentina; Salvetti, Chiara; Riganti, Chiara; Landesman, Yosef; Boccadoro, Mario; Vitale, Candida; Coscia, Marta | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 1-gen-2011 | Coscia, Marta; Rigoni, MICOL MARIA; Riganti, Chiara; Campia, Ivana; Vitale, Candida; Griggio, Valentina; S., Peola; Castella, Barbara; Pantaleoni, Francesca; Sciancalepore, Patrizia; Drandi, Daniela; P., Omedè; Ladetto, Marco; Bosia, Amalia; Boccadoro, Mario; Massaia, Massimo | |
| Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment | 1-gen-2015 | Serra, Sara; Brusa, Davide; Vaisitti, Tiziana; Buonincontri, Roberta; Audrito, Valentina; Coscia, Marta; Rossi, D; Bhavsar, Eb; Furman, Rr; Gaidano, G; Deaglio, Silvia | |
| Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment | 1-gen-2016 | Serra, Sara; Vaisitti, Tiziana; Audrito, Valentina; Bologna, Cinzia; Buonincontri, Roberta; Chen, Shih Shih; Arruga, Francesca; Brusa, Davide; Coscia, Marta; Jaksic, Ozren; Inghirami, Giorgio; Rossi, Davide; Furman, Richard R.; Robson, Simon C.; Gaidano, Gianluca; Chiorazzi, Nicholas; Deaglio, Silvia | |
| Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives | 1-gen-2019 | Coscia, Marta; Vitale, Candida; Cerrano, Marco; Maffini, Enrico; Giaccone, Luisa; Boccadoro, Mario; Bruno, Benedetto | |
| Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma | 1-gen-2015 | Castella, Barbara; Foglietta, Myriam; Sciancalepore, Patrizia; Rigoni, MICOL MARIA; Coscia, Marta; Griggio, Valentina; Vitale, Candida; Ferracini, R; Saraci, E; Omedé, P; Riganti, Chiara; Palumbo, Antonio; Boccadoro, Mario; Massaia, Massimo | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS | 1-gen-2015 | Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, Marta; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS | 1-gen-2015 | Autore, F; Innocenti, I; D'Arena, G; Coscia, Marta; Mondello, P; Pasquale, R; Sica, S; Laurenti, L. | |
| Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience | 1-gen-2016 | Laurenti, Luca; Autore, Francesco; Innocenti, Idanna; D’Arena, Giovanni; Coscia, Marta; Mondello, Patrizia; Chiusolo, Patrizia; Bellesi, Silvia; Efremov, Dimitar G.; Sica, Simona; Mauro, Francesca Romana | |
| B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide | 1-gen-2018 | Fuerstenau, Moritz; Fink, Anna-Maria; Herling, Carmen; Maurer, Christian; Kutsch, Nadine; De La Serna, Javier; Coscia, Marta; Crespo, Marta; Bosch, Francesc; Noesslinger, Thomas; Ghia, Paolo; Kater, Arnon P.; Ritgen, Matthias; Schilhabel, Anke; Stilgenbauer, Stephan; Tausch, Eugen; Fischer, Kirsten; Hallek, Michael J.; Eichhorst, Barbara | |
| Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 1-gen-2011 | A., Tedeschi; Coscia, Marta; D., Rossi; F., Ricci; G., D'Arena; E., Orlandi; V., Belsito Petrizzi; L., Scarfò; Vitale, Candida; E., Vismara; G., Gaidano; E., Morra; Massaia, Massimo; M., Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 1-gen-2010 | A., Tedeschi; Coscia, Marta; D., Rossi; E., Vismara; F., Ricci; Vitale, Candida; E., Morra; G., Gaidano; Massaia, Massimo; M., Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL | 1-gen-2011 | Tedeschi, A; Coscia, Marta; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, Candida; Vismara, E; Gaidano, G; Morra, E; Massaia, Massimo; Montillo, M. | |
| Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial | 1-gen-2011 | A., Tedeschi; Coscia, Marta; D., Rossi; F., Ricci; G., D'Arena; E., Orlandi; V., Belsito Petrizzi; L., Scarfò; Vitale, Candida; E., Vismara; G., Gaidano; E., Morra; Massaia, Massimo; M., Montillo | |
| Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients | 1-gen-2014 | M., Montillo; A., Tedeschi; G., Gaidano; Coscia, Marta; V., Belsito Petrizzi; E., Orlandi; N., Cascavilla; P., Ghia; M., Motta; A., Gallamini; A. M., Frustaci; D., Rossi; L., De Paoli; M., Nichelatti; E., Morra; Massaia, Massimo | |
| Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications | 1-gen-2019 | Arruga, F; Bracciamà, V; Vitale, N; Vaisitti, T; Gizzi, K; Yeomans, A; Coscia, M; D'Arena, G; Gaidano, G; Allan, Jn; Furman, Rr; Packham, G; Forconi, F; Deaglio, S | |
| Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia | 1-gen-2019 | Diop, Fary; Moia, Riccardo; Favini, Chiara; Spaccarotella, Elisa; De Paoli, Lorenzo; Bruscaggin, Alessio; Spina, Valeria; Terzi-di-Bergamo, Lodovico; Arruga, Francesca; Tarantelli, Chiara; Deambrogi, Clara; Rasi, Silvia; Adhinaveni, Ramesh; Patriarca, Andrea; Favini, Simone; Sagiraju, Sruthi; Jabangwe, Clive; Kodipad, Ahad A; Peroni, Denise; Mauro, Francesca R; Del Giudice, Ilaria; Forconi, Francesco; Cortelezzi, Agostino; Zaja, Francesco; Bomben, Riccardo; Rossi, Francesca Maria; Visco, Carlo; Chiarenza, Annalisa; Rigolin, Gian Matteo; Marasca, Roberto; Coscia, Marta; Perbellini, Omar; Tedeschi, Alessandra; Laurenti, Luca; Motta, Marina; Donaldson, David; Weir, Phil; Mills, Ken; Thornton, Patrick; Lawless, Sarah; Bertoni, Francesco; Del Poeta, Giovanni; Cuneo, Antonio; Follenzi, Antonia; Gattei, Valter; Boldorini, Renzo Luciano; Catherwood, Mark; Deaglio, Silvia; Foá, Robin; Gaidano, Gianluca; Rossi, Davide |